尋找研究成果 — 國立成功大學

Liu, C. J., Chuang, W. L., Sheen, I. S., Wang, H. Y., Chen, C. Y., Tseng, K. C., Chang, T. T., Massetto, B., Yang, J. C., Yun, C., Knox, S. J., Osinusi, A., Camus, G., Jiang, D., Brainard, D. M., McHutchison, J. G., Hu, T. H., Hsu, Y. C., Lo, G. H., Chu, C. J. 及其他4, Chen, J. J., Peng, C. Y., Chien, R. N. & Chen, P. J., 2018 三月, 於: Gastroenterology. 154, 4, p. 989-997 9 p.

研究成果: Article › 同行評審

54 引文斯高帕斯（Scopus）

Fucosyl-agalactosyl IgG₁ induces cholangiocarcinoma metastasis and early recurrence by activating tumor-associated macrophage

Chang, T. T., Tsai, H. W. & Ho, C. H., 2018 十一月 21, 於: Cancers. 10, 11, 460.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

Puoti, M., Foster, G. R., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T. T., Lee, S. S., Marinho, R., Dufour, J. F., Pol, S., Hezode, C., Gordon, S. C., Strasser, S. I., Thuluvath, P. J., Zhang, Z., Lovell, S., Pilot-Matias, T. & Mensa, F. J., 2018 八月, 於: Journal of Hepatology. 69, 2, p. 293-300 8 p.

研究成果: Article › 同行評審

69 引文斯高帕斯（Scopus）

Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma

Tsai, H. W., Ho, C. L., Cheng, S. W., Lin, Y. J., Chen, C. C., Cheng, P. N., Yen, C. J., Chang, T. T., Chiang, P. M., Chan, S. H., Ho, C. H., Chen, S. H., Wang, Y. W., Chow, N. H. & Lin, J. C., 2018 三月 14, 於: World journal of gastroenterology. 24, 10, p. 1152-1166 15 p.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient's viremia

Tsai, P., Lin, C. C., Sun, H. Y., Lee, J. C., Chang, T. T. & Young, K. C., 2018 八月, 於: Journal of Microbiology, Immunology and Infection. 51, 4, p. 446-455 10 p.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

2016

Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus

Liu, W. C., Lin, C. P., Cheng, C. P., Ho, C. H., Lan, K. L., Cheng, J. H., Yen, C. J., Cheng, P. N., Wu, I. C., Li, I. C., Chang, B. C. H., Tseng, V. S., Chiu, Y. C. & Chang, T. T., 2016 一月 1, 於: Hepatology International. 10, 1, p. 147-157 11 p.

研究成果: Article › 同行評審

6 引文斯高帕斯（Scopus）

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study

Kao, J. H., Lee, Y. J., Heo, J., Ahn, S. H., Lim, Y. S., Peng, C. Y., Chang, T-T., Torbeyns, A., Hughes, E., Bhore, R. & Noviello, S., 2016 十月 1, 於: Liver International. 36, 10, p. 1433-1441 9 p.

研究成果: Article › 同行評審

20 引文斯高帕斯（Scopus）

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

Kao, J. H., Chien, R. N., Chang, T. T., Peng, C. Y., Hu, T. H., Lo, G. H., Wang, H. Y., Chen, J. J., Yang, J. C., Knox, S. J., Han, L., Mo, H., Mathias, A., Brainard, D. M., Sheen, I. S., Hsu, Y. C., Chu, C. J. & Chuang, W. L., 2016 八月 1, 於: Liver International. 36, 8, p. 1101-1107 7 p.

研究成果: Article › 同行評審

20 引文斯高帕斯（Scopus）

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis c associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin

Ng, K. J., Tseng, C. W., Chang, T. T., Tzeng, S. J., Hsieh, Y. H., Hung, T. H., Huang, H. T., Wu, S. F. & Tseng, K. C., 2016 八月 1, 於: Clinical Interventions in Aging. 11, p. 1035-1041 7 p.

研究成果: Article › 同行評審

6 引文斯高帕斯（Scopus）

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C

Tseng, C. W., Chang, T. T., Tzeng, S. J., Hsieh, Y. H., Hung, T. H., Huang, H. T., Wu, S. F. & Tseng, K. C., 2016 三月 17, 於: Clinical Interventions in Aging. 11, p. 327-334 8 p.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

DeF-GPU: Efficient and effective deletions finding in hepatitis B viral genomic DNA using a GPU architecture

Cheng, C. P., Lan, K. L., Liu, W. C., Chang, T. T. & Tseng, V. S., 2016 十二月 1, 於: Methods. 111, p. 56-63 8 p.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus

Chuang, W. L., Chien, R. N., Peng, C. Y., Chang, T. T., Lo, G. H., Sheen, I. S., Wang, H. Y., Chen, J. J., Yang, J. C., Knox, S. J., Gao, B., Garrison, K. L., Mo, H., Pang, P. S., Hsu, Y. C., Hu, T. H., Chu, C. J. & Kao, J. H., 2016 七月 1, 於: Journal of Gastroenterology and Hepatology (Australia). 31, 7, p. 1323-1329 7 p.

研究成果: Article › 同行評審

22 引文斯高帕斯（Scopus）

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)

LIRA-B Study Team, 2016 五月 1, 於: Journal of Hepatology. 64, 5, p. 1011-1019 9 p.

研究成果: Article › 同行評審

30 引文斯高帕斯（Scopus）

Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase

Ho, C. H., Chuang, H. C., Wu, I. C., Tsai, H. W., Lin, Y. J., Sun, H. Y., Young, K. C., Chiu, Y. C., Cheng, P. N., Liu, W. C., Tan, T. H. & Chang, T. T., 2016, 於: Oncotarget. 7, 31, p. 49765-49776 12 p.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma

Tsai, H. W., Lin, Y. J., Wu, H. C., Chang, T. T., Wu, I. C., Cheng, P. N., Yen, C. J., Chan, S. H., Huang, W. & Su, I. J., 2016 五月 10, 於: Oncotarget. 7, 19, p. 27724-27734 11 p.

研究成果: Article › 同行評審

12 引文斯高帕斯（Scopus）

2014

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study

Manns, M., Pol, S., Jacobson, I. M., Marcellin, P., Gordon, S. C., Peng, C. Y., Chang, T. T., Everson, G. T., Heo, J., Gerken, G., Yoffe, B., Towner, W. J., Bourliere, M., Metivier, S., Chu, C. J., Sievert, W., Bronowicki, J. P., Thabut, D., Lee, Y. J., Kao, J. H. 及其他6, McPhee, F., Kopit, J., Mendez, P., Linaberry, M., Hughes, E. & Noviello, S., 2014, 於: The Lancet. 384, 9954, p. 1597-1605 9 p.

研究成果: Article › 同行評審

280 引文斯高帕斯（Scopus）

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Lin, C. C., Tsai, P., Sun, H. Y., Hsu, M. C., Lee, J. C., Wu, I. C., Tsao, C. W., Chang, T. T. & Young, K. C., 2014 一月 1, 於: Journal of Hepatology. 61, 5, p. 984-993 10 p.

研究成果: Article › 同行評審

33 引文斯高帕斯（Scopus）

Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy

Ho, C. H., Chien, R. N., Cheng, P. N., Liu, C. K., Su, C. S., Wu, I. C., Liu, W. C., Chen, S. H. & Chang, T. T., 2014 十一月, 於: Antiviral Research. 111, p. 121-128 8 p.

研究成果: Article › 同行評審

5 引文斯高帕斯（Scopus）

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA

Chan, H. L. Y., Chan, C. K., Hui, A. J., Chan, S., Poordad, F., Chang, T. T., Mathurin, P., Flaherty, J. F., Lin, L., Corsa, A., Gaggar, A., Subramanian, G. M., McHutchison, J. G., Lee, S. & Gane, E. J., 2014 五月, 於: Gastroenterology. 146, 5, p. 1240-1248 9 p.

研究成果: Article › 同行評審

86 引文斯高帕斯（Scopus）

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: Randomized, double-blind, placebo-controlled study

Tseng, K. C., Chen, C. Y., Tsai, H. W., Chang, T. T., Chuang, W. L., Hsu, P. I., Liu, W. C. & Cheng, P. N., 2014, 於: Antiviral Therapy. 19, 8, p. 755-764 10 p.

研究成果: Article › 同行評審

8 引文斯高帕斯（Scopus）

HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B

Cheng, P. N., Chiu, Y. C., Tsai, H. W., Wang, R. H., Chiu, H. C., Wu, I. C. & Chang, T. T., 2014 十一月 1, 於: Annals of Hepatology. 13, 6, p. 771-780 10 p.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response

Tseng, C. W., Chen, C. Y., Chang, T. T., Tzeng, S. J., Hsieh, Y. H., Hung, T. H., Lee, C. C., Wu, S. F. & Tseng, K. C., 2014 六月 17, 於: PloS one. 9, 6, e100207.

研究成果: Article › 同行評審

5 引文斯高帕斯（Scopus）

2013

Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B

Cheng, P. N., Tsai, H. W., Chiu, Y. C., Ho, C. H., Wu, I. C. & Chang, T. T., 2013 八月 1, 於: Journal of Clinical Virology. 57, 4, p. 323-330 8 p.

研究成果: Article › 同行評審

11 引文斯高帕斯（Scopus）

Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan

Tseng, K. C., Tseng, C. W., Hsieh, Y. H., Chang, C. K., Lai, N. S., Hung, T. H. & Chang, T. T., 2013 八月 1, 於: Human Immunology. 74, 8, p. 978-982 5 p.

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir

Tong, M. J., Kowdley, K. V., Pan, C., Hu, K. Q., Chang, T. T., Han, K. H., Yoon, S. K., Goodman, Z. D., Beebe, S., Iloeje, U. & Tang, H., 2013 四月, 於: Liver International. 33, 4, p. 650-651 2 p.

研究成果: Letter › 同行評審

6 引文斯高帕斯（Scopus）

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

Cheng, S. W., Tsai, H. W., Lin, Y. J., Cheng, P. N., Chang, Y. C., Yen, C. J., Huang, H. P., Chuang, Y. P., Chang, T. T., Lee, C. T., Chao, A., Chou, C. Y., Chan, S. H., Chow, N. H. & Ho, C. L., 2013 十一月 14, 於: PloS one. 8, 11, e80053.

研究成果: Article › 同行評審

37 引文斯高帕斯（Scopus）

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

Gish, R. G., Chang, T. T., Lai, C. L., De Man, R. A., Gadano, A., Llamoso, C. & Tang, H., 2013 十一月 28, 於: Antiviral Therapy. 18, 5, p. 691-698 8 p.

研究成果: Article › 同行評審

16 引文斯高帕斯（Scopus）

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

Sun, H. Y., Lin, C. C., Lee, J. C., Wang, S-W., Cheng, P-N., Wu, I-C., Chang, T-T., Lai, M-D., Shieh, D-B. & Young, K-C., 2013 八月 1, 於: Gut. 62, 8, p. 1193-1203 11 p.

研究成果: Article › 同行評審

26 引文斯高帕斯（Scopus）

2012

Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients

Cheng, C. P., Lee, P. F., Liu, W. C., Wu, I. C., Chin, C. Y., Chang, T. T. & Tseng, V. S., 2012 二月 27, 於: PloS one. 7, 2, e32553.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24

Hsu, C. W., Chao, Y. C., Lee, C. M., Chang, T. T. & Chen, Y. C., 2012 十二月 13, 於: BMC Gastroenterology. 12, 178.

研究成果: Article › 同行評審

7 引文斯高帕斯（Scopus）

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

Yen, C. J., Lin, Y. J., Yen, C. S., Tsai, H. W., Tsai, T. F., Chang, K. Y., Huang, W. C., Lin, P. W., Chiang, C. W. & Chang, T. T., 2012 七月 27, 於: PloS one. 7, 7, e41931.

研究成果: Article › 同行評審

44 引文斯高帕斯（Scopus）

High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B

Pan, C. Q., Tong, M., Kowdley, K. V., Hu, K. Q., Chang, T. T., Lai, C. L., Yoon, S. K., Lee, S. S., Cohen, D., Tang, H. & Tsai, N., 2012 九月, 於: Clinical Gastroenterology and Hepatology. 10, 9, p. 1047-1050.e1

研究成果: Article › 同行評審

12 引文斯高帕斯（Scopus）

Impact of increasing alanine aminotransferase levels within normal range on incident diabetes

Wang, C. S., Chang, T. T., Yao, W. J., Wang, S. T. & Chou, P., 2012 四月, 於: Journal of the Formosan Medical Association. 111, 4, p. 201-208 8 p.

研究成果: Article › 同行評審

30 引文斯高帕斯（Scopus）

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma

Jain, S., Chen, S., Chang, K. C., Lin, Y. J., Hu, C. T., Boldbaatar, B., Hamilton, J. P., Lin, S. Y., Chang, T. T., Chen, S. H., Song, W., Meltzer, S. J., Block, T. M. & Su, Y. H., 2012 四月 20, 於: PloS one. 7, 4, e35789.

研究成果: Article › 同行評審

30 引文斯高帕斯（Scopus）

Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901

Manns, M. P., Akarca, U. S., Chang, T. T., Sievert, W., Yoon, S. K., Tsai, N., Min, A., Pangerl, A., Beebe, S., Yu, M. & Wongcharatrawee, S., 2012 五月 1, 於: Expert Opinion on Drug Safety. 11, 3, p. 361-368 8 p.

研究成果: Article › 同行評審

42 引文斯高帕斯（Scopus）

為 研究成果 進行篩選

搜尋結果

為研究成果進行篩選